388 related articles for article (PubMed ID: 16129525)
1. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.
Wood D;
Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus vaccines and vaccination in Latin America.
Linhares AC; Bresee JS
Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
[TBL] [Abstract][Full Text] [Related]
3. The future of rotavirus vaccines.
Offit PA
Semin Pediatr Infect Dis; 2002 Jul; 13(3):190-5. PubMed ID: 12199615
[TBL] [Abstract][Full Text] [Related]
4. The pentavalent rotavirus vaccine, RotaTeq.
Matson DO
Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus vaccines.
Vesikari T
Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
[TBL] [Abstract][Full Text] [Related]
6. A live attenuated human rotavirus vaccine.
Bernstein DI
Drugs Today (Barc); 2007 May; 43(5):281-91. PubMed ID: 17724495
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
8. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
Black S
Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
[TBL] [Abstract][Full Text] [Related]
10. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
Lepage P; Vergison A
Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
[TBL] [Abstract][Full Text] [Related]
11. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
[TBL] [Abstract][Full Text] [Related]
12. Update on Rotarix: an oral human rotavirus vaccine.
O'Ryan M; Linhares AC
Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
[TBL] [Abstract][Full Text] [Related]
13. Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.
Saleh E; Eichner B; Clark DW; Gagliano ME; Troutman JM; Harrington L; McNeal M; Clements D
J Pediatric Infect Dis Soc; 2018 Feb; 7(1):82-85. PubMed ID: 28340179
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated human rotavirus vaccine, Rotarix.
Bernstein DI
Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
[TBL] [Abstract][Full Text] [Related]
15. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
Clark HF; Offit PA; Plotkin SA; Heaton PM
Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
[TBL] [Abstract][Full Text] [Related]
16. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccine RIX4414 (Rotarix).
Keating GM
Paediatr Drugs; 2006; 8(6):389-95; discussion 396-7. PubMed ID: 17154645
[TBL] [Abstract][Full Text] [Related]
18. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
20. Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults.
Paul A; Babji S; Sowmyanarayanan TV; Dhingra MS; Ramani S; Kattula D; Kang G
Vaccine; 2014 May; 32(25):3094-100. PubMed ID: 24704505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
